Journey Medical Stock Price. Everything You Need To Know About The Journey Medical Stock!
Journey Medical Corp. is a commercial-stage pharmaceutical company headquartered in Scottsdale, Arizona. With 80 full-time employees, the company went IPO on November 12th, 2021. Journey Medical Corp. specializes in developing, acquiring, licensing, and commercializing dermatology products.
The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. With a portfolio of over seven branded and three authorized generic prescription drugs for dermatological conditions, Journey Medical Corp. markets its products in the United States. Its marketed products have been approved by the United States Food and Drug Administration (FDA) for sale and include Qbrexza, Accutane, Targadox, Ximino, and Exelderm Cream and Solution.
Qbrexza is a medicated cloth towelette designed for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug used for the treatment of severe recalcitrant severe acne. Targadox is an oral doxycycline drug that can be used as an adjunctive therapy for acne. Ximino is an oral minocycline drug used for the treatment of moderate to severe acne. Exelderm Cream and Solution is an antifungal medication intended for topical use.
As a potential investor, it’s important to research Journey Medical Corp.’s portfolio of products, as well as the broader market for dermatology products. By keeping an eye on the stocks share price today, premarket, and market cap, investors can gain valuable insights into the company’s potential for growth. While the company’s strong focus on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions may make it an attractive investment, thorough research is necessary to make informed investment decisions.
Journey Medical Stock Price. Everything You Need To Know About The Journey Medical Stock! performance
- Employees 80
- Company HQ Scottsdale
- Website https://journeymedicalcorp.com/
- DERM Asset Type Common Stock
- DERM Market Capitalization 66.4M
- Earnings Per Share -0.21
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Journey Medical is an innovative healthcare company that focuses on the development and commercialization of therapeutic products in dermatology and aesthetics. With a strong portfolio of products targeting various skin conditions, Journey Medical offers a unique opportunity for investors looking to diversify their portfolio. For retail investors from Malaysia, Thailand, Indonesia, and Vietnam, investing in Journey Medical is now more accessible than ever. With Zorion’s investment platform, you can easily invest in real US stocks like Journey Medical and Pre-IPO companies, ensuring an exciting investment journey. To make informed investment decisions, Zorion provides investment insights and recommendations specific to Journey Medical. Our expert team carefully analyzes market trends, financial data, and industry news to guide investors in making smart investment choices. In addition, Zorion offers resources and educational materials to enhance your investment knowledge. Whether you’re new to the stock market or an experienced investor, our in-depth articles and tutorials will empower you to navigate the complexities of investing in Journey Medical from Malaysia, Thailand, Indonesia, and Vietnam. Start your investment journey with Zorion and seize the opportunity to invest in Journey Medical, a promising healthcare company at the forefront of innovative dermatology and aesthetics.
